From Casetext: Smarter Legal Research

United States v. Sansonetti

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF ARKANSAS FAYETTEVILLE DIVISION
Dec 2, 2020
CASE NO. 5:16-CR-50041-TLB-1 (W.D. Ark. Dec. 2, 2020)

Opinion

CASE NO. 5:16-CR-50041-TLB-1

12-02-2020

UNITED STATES OF AMERICA PLAINTIFF v. JOHNATHAN SANSONETTI DEFENDANT


OPINION AND ORDER

Currently before the Court is Defendant Johnathan Sansonetti's pro se Motion for Compassionate Release (Doc. 74). The Court directed the Government to file a response, and the Government did so. See Doc. 79. Mr. Sansonetti filed a Reply and two supplements (Docs. 80, 81, 82). Now that the Motion is ripe and having reviewed all of these filings, the Court finds that Mr. Sansonetti's Motion should be DENIED for the reasons explained below.

I. BACKGROUND

On August 16, 2017, Mr. Sansonetti was sentenced after pleading guilty to one count of possession with the intent to distribute a controlled substance, namely more than 500 grams of a mixture or substance that contained methamphetamine. The Court sentenced Mr. Sansonetti to a 188-month term of imprisonment, a 5-year term of supervised release, a $25,000 fine, and a $100 special assessment (Doc. 56). This sentence was below the original Guideline sentencing range of 324 to 405 months, which was calculated based on the significant quantity of methamphetamine (12.24 kilograms of actual methamphetamine) for which Mr. Sansonetti was held responsible. See Doc. 42, ¶¶ 33-44, 78.

Mr. Sansonetti is currently incarcerated at Lompoc FCI with a projected release date of December 27, 2029. See Fed. Bureau of Prisons, Inmates, https://www.bop.gov/inmateloc/ (last accessed Nov. 30, 2020). He has served approximately 52 months of his original sentence but now moves for compassionate release under 18 U.S.C. § 3582(c)(1) due to his pulmonary fibrosis and asthma on the grounds that he is at a higher risk of a severe infection of COVID-19. The medical records tendered by the Government show that Mr. Sansonetti, who is presently 30 years old, does indeed have asthma and previously tested positive for COVID-19 in May 2020. See Doc. 79-4, p. 6.

II. LEGAL STANDARD

The First Step Act of 2018 ("FSA") permits an inmate to seek a sentence reduction directly from the sentencing court "after the defendant has fully exhausted all administrative rights to appeal a failure of the Bureau of Prisons to bring a motion on the defendant's behalf or the lapse of 30 days from the receipt of such a request by the warden of the defendant's facility, whichever is earlier." 18 U.S.C. § 3582(c)(1)(A)(i). If one of these threshold requirements is satisfied, the court may grant a defendant's motion for a reduction in sentence "after considering factors set forth in section 3553(a) to the extent that they are applicable, if it finds that . . . extraordinary and compelling reasons warrant such a reduction . . . and that such a reduction is consistent with applicable policy statements issued by the Sentencing Commission." 18 U.S.C. § 3582(c)(1)(A)(i). Thus, the Court looks to the Sentencing Commission's policy statement in the United States Sentencing Guidelines ("USSG") as a starting point in determining what constitutes "extraordinary and compelling reasons" under § 3582(c)(1)(A)(i). Application Note 1(A)(ii)(I) of USSG § 1B1.13 indicates that the medical condition of the defendant may provide extraordinary and compelling reasons if the defendant is "suffering from a serious physical or medical condition . . . that substantially diminishes the ability of the defendant to provide self-care within the environment of a correctional facility and from which he or she is not expected to recover." Although the Sentencing Commission has not updated nor adopted a new policy statement since the FSA was enacted, the policy statement nonetheless provides guidance as to what constitutes extraordinary and compelling reasons for the purposes of 18 U.S.C. § 3582(c)(1)(A). See, e.g., United States v. Schmitt, 2020 WL 96904, at *3 (N.D. Iowa Jan. 8, 2020).

III. DISCUSSION

A. Exhaustion of Remedies

The Court's ability to rule on Mr. Sansonetti's Motion is dependent on whether he: (1) fully exhausted his administrative right to appeal the BOP's failure to bring a motion for early release or (2) allowed 30 days to lapse since the warden received his request for early release, whichever event is sooner. 18 U.S.C. § 3582(c)(1)(A)(i). Mr. Sansonetti presents proof that he requested compassionate release from his warden on May 30, 2020. (Doc. 74, p. 11). The Government concedes that Mr. Sansonetti has exhausted his administrative remedies. Therefore, since Mr. Sansonetti petitioned his warden for early release on May 30 and because more than 30 days have lapsed since then, the Court finds that Mr. Sansonetti has satisfied the exhaustion requirement set forth at 18 U.S.C. §3582(c)(1)(A)(i).

B. Extraordinary and Compelling Circumstances

Since Mr. Sansonetti has already recovered from a COVID-19 infection, his argument for compassionate release relies upon his ongoing risk of reinfection of COVID- 19 and the alleged deterioration of his physical condition following his COVID-19 infection. Unfortunately, there is little evidence to support either of these contentions. As to Mr. Sansonetti's risk of reinfection, that risk is speculative. The Centers for Disease Control and Prevention ("CDC") website states that "[c]ases of reinfection with COVID-19 have been reported, but remain rare." Ctrs. for Disease Control and Prevention, Reinfection with COVID-19, https://www.cdc.gov/coronavirus/2019-ncov/your-health/reinfection.html (last accessed Nov. 30, 2020). In short, there is little basis for the Court to conclude that Mr. Sansonetti faces any risk of reinfection. Other courts have agreed that the risk of COVID-19 reinfection does not, by itself, qualify as an extraordinary and compelling reason justifying compassionate release. United States v. Molley, 2020 WL 3498482, at *2-3 (W.D. Wash. June 29, 2020) ("That possibility [of reinfection] is not the same as the concrete and serious threat that infection poses to at-risk inmates, and it is not an extraordinary and compelling reason to release Molley from prison."); but see United States v. Hanson, 2020 WL 3605845, at *4 (D. Or. July 2, 2020) (noting that a prior infection of COVID-19 may not necessarily confer immunity). In the Court's view, at this time, the risk to Mr. Sansonetti posed by a potential reinfection is too speculative to constitute an extraordinary and compelling reason for compassionate release.

The Court's decision on this score is based upon the present scientific uncertainty regarding the risks of reinfection. Should that uncertainty be resolved and the risk become more apparent, the Court may reevaluate whether that risk constitutes an extraordinary and compelling reason to release inmates from prison.

Similarly, Mr. Sansonetti has failed to demonstrate that his physical condition following his COVID-19 infection prevents him from providing self-care within the correctional facility. Mr. Sansonetti argues that his asthma and pulmonary fibrosis were exacerbated by his COVID-19 infection, and his medical records indicate that he requested a chest x-ray and a pulmonary function test (Doc. 79-4, p. 30), but there is no evidence that Mr. Sansonetti's medical conditions have deteriorated to the point that he is unable to provide self-care within the correctional facility. Accordingly, the Court concludes that Mr. Sansonetti has failed to show an extraordinary and compelling basis for a reduction of his sentence.

C. Section 3553(a) Factors

Even if Mr. Sansonetti were able to demonstrate extraordinary and compelling reasons for his release, he is not a suitable candidate for early release considering the Section 3553(a) factors. Section 3582(c)(1) requires the court to consider the factors set forth in 18 U.S.C. § 3553(a) before granting a motion for compassionate release. The circumstances of this case include the fact that Mr. Sansonetti was originally sentenced to 188 months' imprisonment, a downward variance from his Guideline range of 324 to 405 months. Further, counting from the date of his original arrest, it appears that Mr. Sansonetti has now served approximately 29% (52 months) of his original 188-month sentence of imprisonment. In the Court's view, this amount of time is insufficient to reflect the seriousness of his offense conduct, to promote respect for the law, and to afford adequate deterrence to those who would seek to engage in similar criminal activities. Additionally, allowing Mr. Sansonetti to complete his prison sentence in 52 months would create a significant disparity with other defendants who have been held responsible for similarly large quantities of methamphetamine. In sum, after considering and weighing all of the Section 3553(a) factors, the Court continues to find that a sentence of 188 months is just and fair under the totality of the circumstances.

For these reasons, even assuming Mr. Sansonetti has demonstrated extraordinary and compelling medical reasons justifying a reduction of his sentence, the Court finds that the Section 3553(a) factors do not justify compassionate release of Mr. Sansonetti.

To the extent Mr. Sansonetti asks to serve the remainder of his sentence in home confinement, the FSA gives only the BOP—not the Court—the power to decide where Mr. Sansonetti serves his sentence. See 18 U.S.C. §§ 3624(c)(4), 3621(b).

IV. CONCLUSION

IT IS THERFORE ORDERED that Johnathan Sansonetti's pro se Motion for Compassionate Release (Doc. 74) is DENIED.

IT IS SO ORDERED on this 2nd day of December, 2020.

/s/_________

TIMOTHY L. BROOKS

UNITED STATES DISTRICT JUDGE


Summaries of

United States v. Sansonetti

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF ARKANSAS FAYETTEVILLE DIVISION
Dec 2, 2020
CASE NO. 5:16-CR-50041-TLB-1 (W.D. Ark. Dec. 2, 2020)
Case details for

United States v. Sansonetti

Case Details

Full title:UNITED STATES OF AMERICA PLAINTIFF v. JOHNATHAN SANSONETTI DEFENDANT

Court:UNITED STATES DISTRICT COURT WESTERN DISTRICT OF ARKANSAS FAYETTEVILLE DIVISION

Date published: Dec 2, 2020

Citations

CASE NO. 5:16-CR-50041-TLB-1 (W.D. Ark. Dec. 2, 2020)